The U.S. Food and Drug Administration gave Minneapolis-based Medtronic 510(k) clearance for its Reveal LINQ Insertable Cardiac Monitoring system, according to a news release. At one-third the size of ...
ISC23: Late-breaking results from STROKE AF study reinforce importance of long-term continuous cardiac monitoring in ischemic stroke patients Over the first year, 12.5%* of patients in the ICM arm had ...
Please provide your email address to receive an email when new articles are posted on . Insertable cardiac monitoring was estimated to be cost-effective for AF detection in the U.S. This finding was ...
Please provide your email address to receive an email when new articles are posted on . Medtronic announced its artificial intelligence algorithm technology received market clearance from the FDA to ...